Free Trial

Kura Oncology (KURA) SEC Filings & 10K Form

Kura Oncology logo
$9.74 -0.23 (-2.31%)
(As of 12/17/2024 ET)

Recent Kura Oncology SEC Filings

DateFilerForm TypeView
12/05/2024
5:55 PM
Kura Oncology (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/20/2024
4:21 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:32 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
06/07/2024
3:30 PM
Collins Helen Louise (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2024
3:06 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
5:30 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:19 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:34 PM
Kura Oncology (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SC 13G
05/02/2024
3:15 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
3:26 PM
Kura Oncology (Filer)
Form DEF 14A
04/12/2024
3:26 PM
Kura Oncology (Filer)
Form DEFA14A
02/14/2024
11:15 PM
Kura Oncology (Filer)
Form EFFECT
02/14/2024
8:39 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/13/2024
4:23 PM
Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/12/2024
4:33 PM
Flynn James E (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/09/2024
4:21 PM
Kura Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/31/2024
4:30 PM
DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
6:08 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
01/23/2024
8:12 AM
Kura Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/04/2024
3:06 PM
DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Kura Oncology (Issuer)
Powl Brian T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:08 PM
DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:06 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
8:01 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KURA) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners